SEC Filings

Filing	Description	Date Filed	Size
8-K	current report	May 16, 2013	24.8 KB
10-Q	quarterly report	May 10, 2013	377.1 KB
8-K	current report	May 7, 2013	77.6 KB
DEFA14A	definitive proxy statement	Apr 12, 2013	49.4 KB
DEF 14A	definitive proxy statement	Apr 12, 2013	443.3 KB
8-K	current report	Apr 3, 2013	841.3 KB
10-K	annual report	Mar 18, 2013	919.7 KB
8-K	current report	Mar 14, 2013	75.3 KB
CT ORDER	confidential treatment order	Mar 7, 2013	9.0 KB
8-K	current report	Mar 4, 2013	105.3 KB
4	lewis, earl r	Feb 25, 2013	24.8 KB
SC 13G/A	amended statement of beneficial ownership	Feb 14, 2013	23.7 KB
SC 13G/A	amended statement of beneficial ownership	Feb 14, 2013	39.0 KB
SC 13G/A	amended statement of beneficial ownership	Feb 14, 2013	38.9 KB
SC 13G/A	amended statement of beneficial ownership	Feb 14, 2013	43.2 KB
SC 13G/A	amended statement of beneficial ownership	Feb 8, 2013	26.1 KB
SC 13G/A	amended statement of beneficial ownership	Jan 29, 2013	37.6 KB
4	luscinski, susan m	Jan 14, 2013	25.1 KB
4	green, david	Dec 21, 2012	29.5 KB
4	green, david	Dec 19, 2012	28.4 KB
Showing 1-20 of 514 Page: 1 2 3 ... 26  Next 20

Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.